Indoco Remedies · NSE: INDOCO · BSE: 532612

Q4 FY20 results · Jan–Mar 2020

Indoco Remedies reported revenue from operations of ₹271.99 crore and net profit of ₹5.36 crore for Q4 FY20 (Jan–Mar 2020), on a consolidated basis.

Consolidated · ₹ crore
Item	Q4 FY20	Q4 FY19	YoY	Q3 FY20	QoQ
Revenue from operations	271.99	—	—	289.35	−6.0%
Other income	0.50	—	—	0.72	−30.6%
Total income	272.49	—	—	290.07	−6.1%
Profit before tax	7.76	—	—	11.07	−29.9%
Net profit for the period	5.36	—	—	9.10	−41.1%
EPS, basic (₹)	0.58	—	—	0.99	−41.4%
Net margin (%)	2.0	—		3.1

Standalone · ₹ crore
Item	Q4 FY20	Q4 FY19	YoY	Q3 FY20	QoQ
Revenue from operations	272.02	252.02	+7.9%	289.34	−6.0%
Other income	0.49	4.94	−90.1%	0.72	−31.9%
Total income	272.51	256.96	+6.1%	290.06	−6.1%
Profit before tax	7.80	9.40	−17.0%	11.32	−31.1%
Net profit for the period	5.40	11.63	−53.6%	9.34	−42.2%
EPS, basic (₹)	0.59	1.26	−53.2%	1.01	−41.6%
Net margin (%)	2.0	4.6		3.2

Consolidated

Standalone